$9.72
0.11.04%
At Close: -
$9.76
0.040.41%
After Hours: 4:06 PM EDT
15 minutes delayed
Integral Ad Science
IASNASDAQ
Integral Ad Science (NASDAQ:IAS) Stock, Analyst Ratings, Price Targets, Predictions
Integral Ad Science Holding Corp has a consensus price target of $17.19, established from looking at the 73 latest analyst ratings. The last 3 analyst ratings were released from Raymond James, Craig-Hallum, and Loop Capital on May 10, 2024, May 10, 2024, and April 30, 2024. With an average price target of $15.33 between Raymond James, Craig-Hallum, and Loop Capital, there's an implied 57.10% upside for Integral Ad Science Holding Corp from these 3 analyst ratings.
Analyst Firms Making Recommendations1
Raymond James
Craig-Hallum
Benchmark
Loop Capital
Morgan Stanley
1calculated from analyst ratings
Analyst Ratings for Integral Ad Science
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 05/10/2024 | Buy Now | 33.2% | Raymond James | Andrew Marok | $16 → $13 | Maintains | Outperform | Get Alert |
| 05/10/2024 | Buy Now | 84.43% | Craig-Hallum | Jason Kreyer | $20 → $18 | Maintains | Buy | Get Alert |
| 05/07/2024 | Buy Now | — | Benchmark | Mark Zgutowicz | — | Reiterates | → Hold | Get Alert |
| 04/30/2024 | Buy Now | 53.69% | Loop Capital | Rob Sanderson | → $15 | Initiates | → Buy | Get Alert |
| 04/16/2024 | Buy Now | 22.95% | Morgan Stanley | Matthew Cost | $18 → $12 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 04/15/2024 | Buy Now | 22.95% | Barclays | Raimo Lenschow | $16 → $12 | Maintains | Equal-Weight | Get Alert |
| 02/28/2024 | Buy Now | 63.93% | Barclays | Raimo Lenschow | $17 → $16 | Maintains | Equal-Weight | Get Alert |
| 02/28/2024 | Buy Now | 84.43% | Piper Sandler | Matt Farrell | $20 → $18 | Maintains | Overweight | Get Alert |
| 02/28/2024 | Buy Now | 74.18% | Truist Securities | Youssef Squali | $26 → $17 | Maintains | Buy | Get Alert |
| 02/28/2024 | Buy Now | 63.93% | BMO Capital | Brian Pitz | $18 → $16 | Maintains | Outperform | Get Alert |
| 02/28/2024 | Buy Now | 104.92% | Oppenheimer | Jason Helfstein | $25 → $20 | Maintains | Outperform | Get Alert |
| 02/28/2024 | Buy Now | 63.93% | Raymond James | Andrew Marok | $20 → $16 | Downgrade | Strong Buy → Outperform | Get Alert |
| 01/11/2024 | Buy Now | 94.67% | B of A Securities | Omar Dessouky | → $19 | Initiates | → Buy | Get Alert |
| 01/09/2024 | Buy Now | 84.43% | BMO Capital | Brian Pitz | → $18 | Initiates | → Outperform | Get Alert |
| 11/03/2023 | Buy Now | 104.92% | Piper Sandler | Matt Farrell | $23 → $20 | Maintains | Overweight | Get Alert |
| 11/03/2023 | Buy Now | 69.06% | Morgan Stanley | Brian Nowak | $21.5 → $16.5 | Maintains | Overweight | Get Alert |
| 10/12/2023 | Buy Now | 53.69% | Barclays | Raimo Lenschow | $21 → $15 | Maintains | Equal-Weight | Get Alert |
| 08/18/2023 | Buy Now | 94.67% | Baird | Vikram Kesavabhotla | → $19 | Initiates | → Outperform | Get Alert |
| 08/04/2023 | Buy Now | 120.29% | Morgan Stanley | Brian Nowak | $21.5 → $21.5 | Reiterates | Overweight → Overweight | Get Alert |
| 08/04/2023 | Buy Now | 125.41% | Raymond James | Andrew Marok | $23 → $22 | Maintains | Strong Buy | Get Alert |
| 07/21/2023 | Buy Now | 135.66% | Stifel | Mark Kelley | $20 → $23 | Maintains | Buy | Get Alert |
| 07/20/2023 | Buy Now | 156.15% | Truist Securities | Youssef Squali | → $25 | Initiates | → Buy | Get Alert |
| 07/19/2023 | Buy Now | 115.16% | Barclays | Raimo Lenschow | $20 → $21 | Maintains | Equal-Weight | Get Alert |
| 07/10/2023 | Buy Now | 115.16% | Piper Sandler | Matt Farrell | → $21 | Initiates | → Overweight | Get Alert |
| 06/14/2023 | Buy Now | 135.66% | Craig-Hallum | Jason Kreyer | $20 → $23 | Maintains | Buy | Get Alert |
| 06/14/2023 | Buy Now | 120.29% | Morgan Stanley | Brian Nowak | $20 → $21.5 | Maintains | Overweight | Get Alert |
| 06/14/2023 | Buy Now | 104.92% | Barclays | Raimo Lenschow | $17 → $20 | Maintains | Equal-Weight | Get Alert |
| 06/14/2023 | Buy Now | 156.15% | Oppenheimer | Jason Helfstein | $20 → $25 | Maintains | Outperform | Get Alert |
| 06/14/2023 | Buy Now | 135.66% | Raymond James | Andrew Marok | $19 → $23 | Maintains | Strong Buy | Get Alert |
| 06/07/2023 | Buy Now | — | Benchmark | Mark Zgutowicz | — | Initiates | → Hold | Get Alert |
| 05/05/2023 | Buy Now | 104.92% | Morgan Stanley | Brian Nowak | $19 → $20 | Maintains | Overweight | Get Alert |
| 05/05/2023 | Buy Now | 94.67% | Raymond James | Andrew Marok | $18 → $19 | Maintains | Strong Buy | Get Alert |
| 05/02/2023 | Buy Now | 84.43% | Raymond James | Andrew Marok | $17 → $18 | Maintains | Strong Buy | Get Alert |
| 05/02/2023 | Buy Now | 94.67% | Morgan Stanley | Brian Nowak | $14 → $19 | Maintains | Overweight | Get Alert |
| 05/02/2023 | Buy Now | 104.92% | Wells Fargo | Conor Fitzgerald | $16 → $20 | Maintains | Overweight | Get Alert |
| 04/24/2023 | Buy Now | 94.67% | Stifel | Mark Kelley | $15 → $19 | Maintains | Buy | Get Alert |
| 04/17/2023 | Buy Now | 63.93% | Barclays | Raimo Lenschow | $11 → $16 | Maintains | Equal-Weight | Get Alert |
| 04/12/2023 | Buy Now | — | Keybanc | Justin Patterson | — | Initiates | → Sector Weight | Get Alert |
| 03/31/2023 | Buy Now | 84.43% | Craig-Hallum | Jason Kreyer | → $18 | Initiates | → Buy | Get Alert |
| 03/03/2023 | Buy Now | 74.18% | Raymond James | Andrew Marok | $12 → $17 | Maintains | Strong Buy | Get Alert |
| 01/19/2023 | Buy Now | 53.69% | Wells Fargo | Brian Fitzgerald | $16 → $15 | Maintains | Overweight | Get Alert |
| 01/18/2023 | Buy Now | 33.2% | Morgan Stanley | Brian Nowak | $12 → $13 | Maintains | Overweight | Get Alert |
| 11/18/2022 | Buy Now | 2.46% | Barclays | Raimo Lenschow | $8 → $10 | Maintains | Equal-Weight | Get Alert |
| 11/11/2022 | Buy Now | 22.95% | Raymond James | Andrew Marok | $15 → $12 | Maintains | Strong Buy | Get Alert |
| 10/18/2022 | Buy Now | -18.03% | Barclays | Raimo Lenschow | $10 → $8 | Maintains | Equal-Weight | Get Alert |
| 08/08/2022 | Buy Now | 22.95% | Morgan Stanley | Brian Nowak | $13 → $12 | Maintains | Overweight | Get Alert |
| 08/08/2022 | Buy Now | 115.16% | Wells Fargo | Brian Fitzgerald | $28 → $21 | Maintains | Overweight | Get Alert |
| 08/08/2022 | Buy Now | 53.69% | Oppenheimer | Jason Helfstein | $16 → $15 | Maintains | Outperform | Get Alert |
| 07/26/2022 | Buy Now | 84.43% | Raymond James | Aaron Kessler | $20 → $18 | Maintains | Strong Buy | Get Alert |
| 06/24/2022 | Buy Now | 33.2% | Morgan Stanley | Brian Nowak | $15 → $13 | Maintains | Overweight | Get Alert |
| 05/12/2022 | Buy Now | 53.69% | Morgan Stanley | Brian Nowak | $27 → $15 | Maintains | Overweight | Get Alert |
| 05/12/2022 | Buy Now | 176.64% | BMO Capital | Daniel Salmon | $33 → $27 | Maintains | Outperform | Get Alert |
| 05/12/2022 | Buy Now | 94.67% | Oppenheimer | Jason Helfstein | $24 → $19 | Maintains | Outperform | Get Alert |
| 05/12/2022 | Buy Now | 22.95% | Barclays | Raimo Lenschow | $17 → $12 | Maintains | Equal-Weight | Get Alert |
| 05/12/2022 | Buy Now | 104.92% | Raymond James | Andrew Marok | $27 → $20 | Maintains | Strong Buy | Get Alert |
| 05/12/2022 | Buy Now | 186.89% | Wells Fargo | Brian Fitzgerald | $31 → $28 | Maintains | Overweight | Get Alert |
| 04/19/2022 | Buy Now | 74.18% | Barclays | Raimo Lenschow | $20 → $17 | Maintains | Equal-Weight | Get Alert |
| 03/21/2022 | Buy Now | 176.64% | Raymond James | Andrew Marok | $26 → $27 | Upgrade | Outperform → Strong Buy | Get Alert |
| 03/04/2022 | Buy Now | 166.39% | Stifel | Mark Kelley | $25 → $26 | Maintains | Buy | Get Alert |
| 03/04/2022 | Buy Now | 166.39% | Raymond James | Andrew Marok | $28 → $26 | Maintains | Outperform | Get Alert |
| 02/01/2022 | Buy Now | 156.15% | Stifel | Mark Kelley | → $25 | Initiates | → Buy | Get Alert |
| 11/11/2021 | Buy Now | 186.89% | Raymond James | Andrew Marok | — | Maintains | Outperform | Get Alert |
| 08/13/2021 | Buy Now | 125.41% | Barclays | Raimo Lenschow | — | Maintains | Equal-Weight | Get Alert |
| 08/13/2021 | Buy Now | 145.9% | Morgan Stanley | — | — | Maintains | Overweight | Get Alert |
| 08/13/2021 | Buy Now | 176.64% | BMO Capital | Daniel Salmon | — | Maintains | Outperform | Get Alert |
| 07/26/2021 | Buy Now | 135.66% | Oppenheimer | — | — | Initiates | → Outperform | Get Alert |
| 07/26/2021 | Buy Now | 135.66% | Morgan Stanley | Brian Nowak | — | Initiates | → Overweight | Get Alert |
| 07/26/2021 | Buy Now | 125.41% | Raymond James | Andrew Marok | — | Initiates | → Outperform | Get Alert |
| 07/26/2021 | Buy Now | 166.39% | Wells Fargo | Brian Fitzgerald | — | Initiates | → Overweight | Get Alert |
| 07/26/2021 | Buy Now | 115.16% | Barclays | — | — | Initiates | → Equal-Weight | Get Alert |
| 07/26/2021 | Buy Now | 135.66% | Jefferies | Brent Thill | — | Initiates | → Buy | Get Alert |
| 07/26/2021 | Buy Now | 135.66% | Evercore ISI Group | Mark Mahaney | — | Initiates | → Outperform | Get Alert |
| 07/26/2021 | Buy Now | 156.15% | BMO Capital | Daniel Salmon | — | Initiates | → Outperform | Get Alert |
FAQ
What is the target price for Integral Ad Science (IAS) stock?
The latest price target for Integral Ad Science (NASDAQ:IAS) was reported by Raymond James on May 10, 2024. The analyst firm set a price target for $13.00 expecting IAS to rise to within 12 months (a possible 33.20% upside). 24 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Integral Ad Science (IAS)?
The latest analyst rating for Integral Ad Science (NASDAQ:IAS) was provided by Raymond James, and Integral Ad Science maintained their outperform rating.
When was the last upgrade for Integral Ad Science (IAS)?
The last upgrade for Integral Ad Science Holding Corp happened on March 21, 2022 when Raymond James raised their price target to $27. Raymond James previously had an outperform for Integral Ad Science Holding Corp.
When was the last downgrade for Integral Ad Science (IAS)?
The last downgrade for Integral Ad Science Holding Corp happened on April 16, 2024 when Morgan Stanley changed their price target from $18 to $12 for Integral Ad Science Holding Corp.
When is the next analyst rating going to be posted or updated for Integral Ad Science (IAS)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Integral Ad Science, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Integral Ad Science was filed on May 10, 2024 so you should expect the next rating to be made available sometime around May 10, 2025.
Is the Analyst Rating Integral Ad Science (IAS) correct?
While ratings are subjective and will change, the latest Integral Ad Science (IAS) rating was a maintained with a price target of $16.00 to $13.00. The current price Integral Ad Science (IAS) is trading at is $9.76, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.